Accord Logo

Intended for UK patients and members of the public

SmPC - IMULDOSA® 130 mg concentrate for solution for infusion (active: ustekinumab): Change history

Back to products
  • View Summary of Product Characteristics (SmPC - IMULDOSA® 130 mg concentrate for solution for infusion (active: ustekinumab))

    Last updated on this site: 11 Apr 2025

    New Product Launch. Launch date 10/04/2025.

    View change history

    • Changes: (Updated: 11 Apr 2025)

      New Product Launch. Launch date 10/04/2025.

    Back to Top

    View product information as a: